CLINICAL RESEARCH FOR ALL Trademark

Trademark Overview


On Friday, April 8, 2022, a trademark application was filed for CLINICAL RESEARCH FOR ALL with the United States Patent and Trademark Office. The USPTO has given the CLINICAL RESEARCH FOR ALL trademark a serial number of 97353259. The federal status of this trademark filing is REGISTERED as of Tuesday, February 13, 2024. This trademark is owned by Alcanza Clinical Research, LLC. The CLINICAL RESEARCH FOR ALL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

scientific research in the field of health care; clinical medical research; medical and scientific research, namely, conducting clinical trials for others; scientific research in the nature of conducting clinical trials for others; clinical medical and scientific research in the form of clinical trials of drugs for third party manufacturers; clinical scientific research in the form of clinical trials of drugs for third party manufacturers; laboratory research in the field of pharmaceuticals
clinical research for all

General Information


Serial Number97353259
Word MarkCLINICAL RESEARCH FOR ALL
Filing DateFriday, April 8, 2022
Status700 - REGISTERED
Status DateTuesday, February 13, 2024
Registration Number7305997
Registration DateTuesday, February 13, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 11, 2023

Trademark Statements


Disclaimer with Predetermined Text"CLINICAL RESEARCH"
Goods and Servicesscientific research in the field of health care; clinical medical research; medical and scientific research, namely, conducting clinical trials for others; scientific research in the nature of conducting clinical trials for others; clinical medical and scientific research in the form of clinical trials of drugs for third party manufacturers; clinical scientific research in the form of clinical trials of drugs for third party manufacturers; laboratory research in the field of pharmaceuticals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 12, 2022
Primary Code042
First Use Anywhere DateThursday, June 30, 2022
First Use In Commerce DateThursday, June 30, 2022

Trademark Owner History


Party NameAlcanza Clinical Research, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressLake Mary, FL 32746

Party NameAlcanza Clinical Research, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLake Mary, FL 32746

Party NameAlcanza Clinical Research, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMethuen, MA 01844

Trademark Events


Event DateEvent Description
Tuesday, February 13, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 13, 2024REGISTERED-PRINCIPAL REGISTER
Friday, January 12, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, January 11, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, December 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 14, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 5, 2023USE AMENDMENT FILED
Thursday, December 14, 2023SOU EXTENSION 1 GRANTED
Tuesday, December 5, 2023SOU EXTENSION 1 FILED
Wednesday, December 13, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 5, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 5, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, June 6, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 11, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 11, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 7, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 7, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 7, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 26, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 26, 2023NON-FINAL ACTION E-MAILED
Thursday, January 26, 2023NON-FINAL ACTION WRITTEN
Thursday, January 26, 2023ASSIGNED TO EXAMINER
Tuesday, April 12, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 12, 2022NEW APPLICATION ENTERED